The FDA’s recent decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who…
Browsing: FDA
Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with drugmakers.
Interruptions in the supply of neurosurgical patties, sponges and strips are expected to continue through 2026.
In response to emergency appeals filed by Danco and GenBioPro, on May 4, 2026, Justice Alito issued a one-week administrative…
The U.S. Food and Drug Administration on April 29 said tested samples of infant formula available in the country contained…
The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class…
The agency’s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F. Kennedy Jr.…
Combining the disparate databases used to detect potential issues with drugs, vaccines and other products into a single dashboard will…
Months after promising help for “hundreds of thousands of kids,” the FDA approved the decades-old medicine for a disease documented…
Prasad’s planned departure, expected at the end of April, culminates a tumultuous term in which he reworked vaccine guidelines and…
Moderna said the agency agreed to move forward and review its application for the mRNA-based shot.
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host…
The U.S. Food and Drug Administration on Tuesday launched a broad review of a long-used synthetic preservative used in packaged…
